# Alexza Pharmaceuticals, Inc., Fremont, CA – FDA Inspections

Source: https://www.keypedia.com/companies/alexza-pharmaceuticals-inc/4b71680e-1a0e-4237-8b2a-2e2c32c5c8fe

> Inspection records and compliance data for Alexza Pharmaceuticals, Inc. in Fremont, California. 10 FDA inspections on record (1 OAI), last inspected December 19, 2025.

---

## Details

- Name: Alexza Pharmaceuticals, Inc.
- FEI Number: 3007119522
- Address Line 1: 6550 Dumbarton Cir Ste A
- City: Fremont
- State: California
- Zip Code: 94555
- Country Name: United States
- Address: 6550 Dumbarton Cir Ste A, Fremont, California 94555, United States
- Country: United States

## Related Documents

- FDA Inspection 1300206 - Alexza Pharmaceuticals, Inc. - 2025-12-19 — source: FDA, date: December 19, 2025
- [FDA Inspection 1281572 - Alexza Pharmaceuticals, Inc. - 2025-08-01](https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/8e1f7e72-88f4-4c2e-940e-2279b9592391) — source: FDA, date: August 1, 2025
- FDA Inspection 1281572 - Alexza Pharmaceuticals, Inc. - 2025-08-01 — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2025
- FDA Inspection 1227246 - Alexza Pharmaceuticals, Inc. - 2023-12-22 — classification: No Action Indicated (NAI), source: FDA, date: December 22, 2023
- [FDA Inspection 1109014 - Alexza Pharmaceuticals, Inc. - 2019-09-26](https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/316cd956-10ab-4ffb-937c-3b3bba844f2b) — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2019
- FDA Inspection 926541 - Alexza Pharmaceuticals, Inc. - 2015-05-21 — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2015
- [FDA Inspection 926541 - Alexza Pharmaceuticals, Inc. - 2015-05-21](https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/807afa89-bcab-457f-8c8f-51714e067230) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 21, 2015
- FDA Inspection 866702 - Alexza Pharmaceuticals, Inc. - 2014-02-13 — classification: No Action Indicated (NAI), source: FDA, date: February 13, 2014
- [FDA Inspection 863458 - Alexza Pharmaceuticals, Inc. - 2014-01-22](https://www.keypedia.com/records/fda_inspections/alexza-pharmaceuticals-inc/7be34a5c-2eaf-4898-9f06-cd30797a8150) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 22, 2014
- FDA Inspection 807836 - Alexza Pharmaceuticals, Inc. - 2012-11-08 — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2012

## Related Companies

- [3M Company](https://www.keypedia.com/companies/3m-company/09a7a39c-a8e7-459a-9f6f-22733c1bdce3)
- [Alkermes Inc](https://www.keypedia.com/companies/alkermes-inc/c20f3273-400d-4b2e-a485-214b986ed7c2)
- [Blistex Inc](https://www.keypedia.com/companies/blistex-inc/5268fd01-ac61-4bf8-a1ca-192da45c825a)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/311196d9-b80d-4a77-a294-dab360325781)
- [LTS Therapy Systems, LLC](https://www.keypedia.com/companies/lts-therapy-systems-llc/2bbbf391-d6c1-4789-a5da-63a32fda9b30)
- [Shire Human Genetic Therapies, Inc.](https://www.keypedia.com/companies/shire-human-genetic-therapies-inc/7051823d-8cc7-4d72-8a82-a0de9bbb9497)
- [Zydus Lifesciences Limited](https://www.keypedia.com/companies/zydus-lifesciences-limited/1c40f7df-1e2e-48cb-b768-ad55e472ad64)
- [Murty Pharmaceuticals, Inc](https://www.keypedia.com/companies/murty-pharmaceuticals-inc/8d7f8024-f6fd-463e-b94f-63cd3b745e96)
- [Agnitio Inc](https://www.keypedia.com/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb)
- [Tedor Pharma, Inc.](https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d)